Visit the NEW CoM Homepage |  University of Kentucky |  UK HealthCare |  Give to Medicine |  Diversity  
UK College of Medicine logo Link to the College of Medicine web site
  • ed2
  • rs
  • cs5
  • ad1

Internal Medicine - Endocrinology

INTERNAL MEDICINE

Endocrinology

BARNSTABLE BROWN OBESITY AND DIABETES RESEARCH DAY

CONTACT

Philip A. Kern, M.D.

Picture of Dr. Kern   
   
          Professor, Division of Endocrinology and Molecular Medicine
          Director, Barnstable Brown Kentucky Diabetes and Obesity Center
          Director, Center for Clinical and Translational Sciences


          Best Doctors logo







 

Contact Information

Training and Publications

University of Kentucky Research Summary (PDF)
521-A Charles T. Wethington Building Publication Listing on PubMed
900 South Limestone Street
Lexington, KY 40536-0200  
Telephone: (859) 323-5821  
FOR PATIENT INQUIRIES PLEASE CALL : (859) 323-2232  
Fax: (859) 323-5707  
 

Clinical Interests

Dr. Kern is an Endocrinologist and sees patients with diabetes and other Endocrinology disorders.

 

Research Topics

Insulin resistance, diabetes, and obesity-related metabolic complications
Inflammation in adipose tissue and muscle
omega-3 fatty acids and inflammation
Translational regulation of gene expression
Lipoprotein metabolism

 

Research Interests

Dr. Kern is engaged in both basic and clinical research related to obesity, metabolic syndrome, and diabetes. In clinical studies, Dr. Kern and his colleagues examine adipose tissue and muscle gene expression in relation to insulin resistance. Current themes involve a detailed evaluation of the role of tissue lipotoxicity and inflammation as important factors in obesity related insulin resistance. Current studies are examining the role of omega-3 fatty acids in metabolic syndrome as possible anti-inflammatory agents and as modulators of PPARg. Other studies are examining muscle and adipose tissue inflammation and fibrosis in response to exercise. The potential mechanisms of inflammation-mediated insulin resistance, and possible therapeutic interventions, are being studied both in vitro and in vivo.

Other research involves the gene expression of lipoprotein lipase (LPL), which is an important enzyme in adipose tissue that is involved in triglyceride metabolism, diabetes, and obesity. In recent studies, Dr. Kern’s lab identified components of an RNA binding complex that inhibited LPL translation in response to catecholamines. These data suggest a duel role for cAMP stimulation, resulting in a coordinated response to rapidly promote release of adipocyte lipid and inhibition of lipogenesis, all through posttranscriptional mechanisms.

 
 
Comments and Corrections |  An Equal Opportunity University |  Jobs  |  Terms, Conditions and Accessibility Statements   |  Privacy
© 2012, University of Kentucky College of Medicine, 138 Leader Ave., Lexington, Kentucky, USA 40506-9983
Student Affairs: (859) 323-5261 · Admissions: (859) 323-6161 · Clinical Questions: (859) 257-1000 · Dean's Office: (859) 323-6582
Page last updated Tuesday, September 24, 2013